Abbreviations: (FPG) fasting plasma glucose, (IS) insulin sensitivity, (W) weight
Accordi ng to product inserts, the recommended starting doses for basal insulin in type 2 diabetes is 10-20 U or 0.1-0.2 U/kg. Although usually not causing hypoglycemia, these are far short of the eventual dose at the glycemic goal, prolonging the period of titration and increasing the chance of failure to reach goal. We postulated that larger initial doses determined by the patient's insulin sensitivity (IS) would accelerate goal attainment without increasing the risk of hypoglycemia.
Days-to-glycemic goal were compared between two methods of determining the starting dose of basal analog insulin, weight (W) versus a pre-insulin-treatment assessment of IS.
In uncontrolled insulin-naïve type 2 diabetes subjects, IS was determined by the fasting plasma glucose (FPG) decline in 4 h following subcutaneous insulin aspart, 0.1 U/kg. The IS dose was calculated from the formula LETTER TO EDITOR Figure 1 . The mean once-nightly insulin detemir dose (and standard error) in that group starting dose determined by W (0.1 U/kg; n = 10) compared with that dose determined by a pretreatment test of IS (n = 9). 500/((FPG BASELINE -FPG 4th HOUR )/U ASPART ). Once-nightly insulin detemir, 0.1 U/kg, was titrated every 3 days to achieve a 3-day mean FPG of <110 mg/dl. On the third day, subjects were randomized (1:1) to begin titration (W group) or to increase to the IS dose over 3 days. On the ninth day, the IS group began titration. Compliance was supported by weekly telephone calls and clinic visits every 4 weeks during the 12-week study.
Without an increase in the hypoglycemia incidence, the IS group (n = 9) achieved target FPG in 27.8 ± 23.7 versus 38.2 ± 25.6 days (p = .186) for the W group (n = 10). The mean IS dose at start and at goal was significantly higher than in the W group, 60.7 ± 23.6 versus 11.0 ± 2.4 U (p < .001) and 79.0 ± 35.7 versus 45.0 ± 25.9 U (p = .0142) despite similar baseline IS, 8.06 ± 3.18 versus 8.19 ± 3.52 mg/dl/U, respectively (p = .456). The titration course of both approaches is seen in Figure 1 .
